Atrial Fibrillation Devices Market Size By Product (EP Ablation Catheters {Radiofrequency, Laser, Cryoablation, Ultrasound, Microwave}, EP Diagnostic Catheters {Fixed Curve Catheters, Steerable Catheters, Advanced Mapping Catheters}, Mapping and Recording Systems, Cardiac Monitors or Implantable Loop Recorder, Access Devices, Intracardiac Echocardiography, Left Atrial Appendage Closure Devices), By End-use (Hospitals, Cardiac Centres, Ambulatory Surgical Centres), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025

Atrial Fibrillation Devices Market Size

Atrial Fibrillation Devices Market size surpassed USD 5 billion in 2018 and is anticipated to grow at over 14.2% CAGR from 2019 to 2025. Also, the number of atrial fibrillation devices sold were around 1.5 million units in 2018 and will reach approximately 4 million units by 2025.
 

Rising adoption rate of advance technologies and presence of sophisticated healthcare infrastructure will be the major factors driving the atrial fibrillation devices market growth. Moreover, rising geriatric population in the North American region will augment the market expansion. Furthermore, availability of favorable reimbursement scenario in developed regions should prove to be high impact rendering factor.
 

Increasing prevalence of cardiovascular diseases in developing regions owing to surge in sedentary lifestyle and increasing habit of binge eating will fuel acceptance rates in developed as well as in certain areas in developing nations.

However, high price of devices will be one of the major reasons impeding the adoption rates in under-developed and few developing countries. High price factor will continue to hinder the atrial fibrillation devices market value during the forecast timeframe. Also, lack of obligatory infrastructure to conduct smooth atrial fibrillation procedures in certain emerging regions might hamper the industry expansion.
 

Atrial Fibrillation Devices Market Analysis

EP ablation catheters segment in the atrial fibrillation devices market was valued at USD 1.55 billion in 2018 led by their wide use in atrial fibrillation procedure care units. Ablation catheters are currently the mainstream interface used in majority of regions across the globe. In addition, acceptance rate of catheter ablation system is steadily increasing due to growing procedural success rate in patients suffering from paroxysmal, persistent and permanent conditions of atrial fibrillation. A considerable proportion of patients suffering from acute atrial fibrillation mostly prefer minimally invasive surgeries and catheter ablation satisfies the condition thus, holding prominent share in the market.
 

The atrial fibrillation devices market for mapping and recording systems will showcase 14% growth rate through 2025. Modern advanced mapping systems used in AF ablation have revealed promising results and could pave the way to a new epoch of individual ablation and substrate characterization strategies. The recent technological enhancements in the mapping systems have resulted in better visualization of multiple catheters simultaneously, thus, propelling product demand. Increasing adoption rate of these devices in developed and emerging regions has resulted in an upward trajectory of growth.
 

The hospitals segment in the atrial fibrillation devices market crossed USD 2.48 billion in 2018. A substantial proportion of atrial fibrillation surgeries happen in hospital settings; thus, demand for these devices are the highest. The hospital end-use segment will continue to lead, due to rising number of multi-specialty hospitals and people’s preference for hospitals over other healthcare settings.
 

The cardiac centers segment is estimated to attain a CAGR of 15.2% till 2025. cardiac centers are being the most preferred setting in developed as well as developing countries. Hence, usage of advanced technologies in clinics and surgical centers should propel the industry progression.
 

Germany atrial fibrillation devices market is expected to increase with growing application of minimally invasive catheter ablation procedures. Additionally, approachable reimbursement scenario of the country should boost the demand for innovative atrial fibrillation devices. 
 

U.S. market size was over USD 2.25 billion in 2018 driven by the country being the primary new technology adopter as well as for being the most developed region to provide state of art facilities for atrial fibrillation procedures. It will witness modest growth credited to relatively low addressable needs.
 

China atrial fibrillation devices market is poised to expand at more than 17.6% CAGR by 2025 impelled by the rising prevalence of cardiac diseases due to sudden transition of lifestyle-related habits and growing trends of tobacco intake in millennials. Furthermore, expansion of new healthcare facilities, development of hospitals, and growing acceptance of private clinics have spurred the industry revenue. Current unmet need and increasing number of baby boomers who are prone to cardiac diseases are primary factors to stimulate the market progression during the forecast timeframe.
 

Atrial Fibrillation Devices Market Share

• Abbott Laboratories
• Johnson & Johnson
• Atricure Inc
• Microport Scientific Corporation
• Boston Scientific Corporation
• St. Jude medical, Inc
• Medtronic Plc
• Koninklijke Philips N.V.
• Siemens AG

are some of the major companies operating in the atrial fibrillation devices market. These key industry participants will hold maximum revenue share owing to better brand recognition, strong financial position and finest quality products. These leaders executed various strategies with the aim to gain competitive advantage over its peers. Key strategies implemented by the players in the market include novel product launches, acquisition strategy, expansion strategy, etc.
 

Industry Background

Atrial fibrillation is recognized as one of the common valvular diseases among individuals due to various factors such as high alcohol intake, hypertension, obesity, etc. However, with the growing acceptance rate of advance technology in industry, devices and procedures providing diagnosis and treatment are also increasing. To address the unmet needs globally, few multinational companies started manufacturing innovative offerings to the healthcare industry across the world. With ever growing need in the face of growing cardiac diseases, numerous products were launched in the market. By the beginning of 2000’s, cutting-edge technologies such as advance mapping and recording systems used in catheter ablation procedures were made available by significant medical devices manufacturing firms. An era of expertise has been established lately that makes atrial fibrillation not only curable but also preventable.
 

Atrial fibrillation devices market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2014 to 2025, for the following segments:

Click here to Buy Section of this Report

Market, by Product

• EP Ablation Catheters
• EP Diagnostic Catheters
• Mapping and Recording Systems
• Cardiac Monitors or Implantable Loop Recorder
• Access Devices
• Intracardiac Echocardiography (ICE)
• Left Atrial Appendage (LAA) Closure Devices

Market, by End-use

• Hospitals
• Cardiac Centers
• Ambulatory Surgical Centers
• Others

The above information is provided for the following regions/countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Russia
  • Poland
  • Switzerland
  • Belgium
  • Czech Republic
  • Netherlands
  • Sweden
  • Hungary
  • Austria
  • Portugal
  • Denmark
  • Norway
  • Finland
  • Ireland
  • Turkey
  • Greece
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Taiwan
  • New Zealand
  • Singapore
• Latin America
  • Brazil
  • Argentina
  • Venezuela
  • Columbia
  • Mexico
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Egypt